Complementary and alternative interventions in atopic dermatitis

Immunology and Allergy Clinics of North America

Volumn 30, Issue 3, 2010, Pages 411-424

  Lee, Joohee ^a   Bielory, Leonard ^b,c  

^a MAYO CLINIC   (United States)

^b Center for Environmental Prediction   (United States)

^c STARx Allergy and Asthma Center   (United States)

Author keywords

Atopic dermatitis; Biologically based therapies; Chinese herbal therapy; Complementary and alternative medicine; Herbal medicine

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AOA; ASTRAGALIN; ATOPICLAIR; BAKUMIJIOGAN; BAMBUSAE CAULIS EXTRACT; BU ZHONG YI QI TANG; CHINESE DRUG; COLECALCIFEROL; CYANOCOBALAMIN; DA 9102; GAMMA LINOLENIC ACID; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; MAS 063DP; PENTAHERB; PENTAHERBS; PERSIMMON EXTRACT; PLACEBO; PRIMROSE OIL; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VITAMIN D; ZEMAPHYTE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ALTERNATIVE MEDICINE; APPLICATION SITE IRRITATION; ATOPIC DERMATITIS; BAMBUSA; BAMBUSAE CAULIS; CATARACT; CHINESE MEDICINE; CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; FERMENTATION TECHNIQUE; FOOD AND DRUG ADMINISTRATION; GENE OVEREXPRESSION; HOMEOPATHY; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LACTOBACILLUS RHAMNOSUS; LOW DRUG DOSE; MANIPULATIVE MEDICINE; NAUSEA; NONHUMAN; PERSIMMON; PLANT LEAF; PLANT STEM; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VITAMIN SUPPLEMENTATION;

ANIMALS; COMPLEMENTARY THERAPIES; COST OF ILLNESS; DERMATITIS, ATOPIC; DIET THERAPY; HUMANS; IMMUNE TOLERANCE; MIND-BODY THERAPIES; PHYTOTHERAPY; PROBIOTICS; TH1-TH2 BALANCE; VITAMINS;

EID: 77955488545     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2010.06.006     Document Type: Review

References (74)

1. Eisenberg D.M. Advising patients who seek alternative medical therapies. Ann Intern Med 1997, 127(1):61-69.
2. McNamara S.H. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update. Food Drug Law J 1996, 51(2):313-318.
3. Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Ann Allergy Asthma Immunol 2004, 93(2 Suppl 1):S45-S54.
4. Mainardi T., Kapoor S., Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 2009, 123(2):283-294. [quiz 295-86].
5. Bielory L., Lupoli K. Herbal interventions in asthma and allergy. J Asthma 1999, 36(1):1-65.
6. Jensen P. Alternative therapy for atopic dermatitis and psoriasis: patient-reported motivation, information source and effect. Acta Derm Venereol 1990, 70(5):425-428.
7. Hughes R., Ward D., Tobin A.M., et al. The use of alternative medicine in pediatric patients with atopic dermatitis. Pediatr Dermatol 2007, 24(2):118-120.
8. Anderson P.C., Dinulos J.G. Atopic dermatitis and alternative management strategies. Curr Opin Pediatr 2009, 21(1):131-138.
9. Kang K.D., Kang S.M., Yim H.B. Herbal medication aggravates cataract formation: a case report. J Korean Med Sci 2008, 23(3):537-539.
10. Ferguson J.E., Chalmers R.J., Rowlands D.J. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol 1997, 136(4):592-593.
11. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000, 143(5):923-929.
12. Engler R.J., With C.M., Gregory P.J., et al. Complementary and alternative medicine for the allergist-immunologist: where do I start?. J Allergy Clin Immunol 2009, 123(2):309-316.
13. Ramsay H.M., Goddard W., Gill S., et al. Herbal creams used for atopic eczema in Birmingham, UK illegally contain potent corticosteroids. Arch Dis Child 2003, 88(12):1056-1057.
14. Smits H.H., Engering A., van der Kleij D., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115(6):1260-1267.
15. Prescott S.L., Dunstan J.A., Hale J., et al. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 2005, 35(12):1557-1564.
16. Rautava S., Kalliomaki M., Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 2005, 116(1):31-37.
17. Kalliomaki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357(9262):1076-1079.
18. Kalliomaki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361(9372):1869-1871.
19. Kopp M.V., Hennemuth I., Heinzmann A., et al. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121(4):e850-e856.
20. Taylor A.L., Dunstan J.A., Prescott S.L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007, 119(1):184-191.
21. Soh S.E., Aw M., Gerez I., et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009, 39(4):571-578.
22. Tang M.L. Probiotics and prebiotics: immunological and clinical effects in allergic disease. Nestle Nutr Workshop Ser Pediatr Program 2009, 64:219-238.
23. van der Aa L.B., Heymans H.S., van Aalderen W.M., et al. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol 2009, 21(2):e355-e367.
24. Kopp M.V., Salfeld P. Probiotics and prevention of allergic disease. Curr Opin Clin Nutr Metab Care 2009, 12(3):298-303.
25. Kuitunen M., Kukkonen K., Juntunen-Backman K., et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009, 123(2):335-341.
26. Kukkonen K., Savilahti E., Haahtela T., et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(1):192-198.
27. Moro G., Arslanoglu S., Stahl B., et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006, 91(10):814-819.
28. Ziegler E., Vanderhoof J.A., Petschow B., et al. Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. J Pediatr Gastroenterol Nutr 2007, 44(3):359-364.
29. Weston S., Halbert A., Richmond P., et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005, 90(9):892-897.
30. Volz T., Biedermann T. Hautarzt 2009, 60(10):795-801. [in German].
31. Rowe A., Farrell A.M., Bunker C.B. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997, 136(1):18-23.
32. Taniuchi S., Kojima T., Hara Mt K., et al. Increased serum nitrate levels in infants with atopic dermatitis. Allergy 2001, 56(7):693-695.
33. Morita H., Semma M., Hori M., et al. Clinical application of nitric oxide synthase inhibitor for atopic dermatitis. Int J Dermatol 1995, 34(4):294-295.
34. Stucker M., Pieck C., Stoerb C., et al. Topical vitamin B12-a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial. Br J Dermatol 2004, 150(5):977-983.
35. Erkkola M., Kaila M., Nwaru B.I., et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy 2009, 39(6):875-882.
36. Back O., Blomquist H.K., Hernell O., et al. Does vitamin D intake during infancy promote the development of atopic allergy?. Acta Derm Venereol 2009, 89(1):28-32.
37. Patrizi A., Raone B., Neri I. Atopiclair. Expert Opin Pharmacother 2009, 10(7):1223-1230.
38. Patrizi A., Capitanio B., Neri I., et al. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients. Pediatr Allergy Immunol 2008, 19(7):619-625.
39. Niwa Y., Tominaga K., Yoshida K. Successful treatment of severe atopic dermatitis-complicated cataract and male infertility with a natural product antioxidant. Int J Tissue React 1998, 20(2):63-69.
40. Lovell C.R., Burton J.L., Horrobin D.F. Treatment of atopic eczema with evening primrose oil. Lancet 1981, 1(8214):278.
41. Wright S., Burton J.L. Oral evening-primrose-seed oil improves atopic eczema. Lancet 1982, 2(8308):1120-1122.
42. Bamford J.T., Gibson R.W., Renier C.M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol 1985, 13(6):959-965.
43. Henz B.M., Jablonska S., van de Kerkhof P.C., et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 1999, 140(4):685-688.
44. Skogh M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol 1986, 15(1):114-115.
45. Biagi P.L., Bordoni A., Masi M., et al. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp Clin Res 1988, 14(4):285-290.
46. Schalin-Karrila M., Mattila L., Jansen C.T., et al. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br J Dermatol 1987, 117(1):11-19.
47. Stonemetz D. A review of the clinical efficacy of evening primrose. Holist Nurs Pract 2008, 22(3):171-174.
48. Takwale A., Tan E., Agarwal S., et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 2003, 327(7428):1385.
49. van Gool C.J., Thijs C., Henquet C.J., et al. Gamma-linolenic acid supplementation for prophylaxis of atopic dermatitis-a randomized controlled trial in infants at high familial risk. Am J Clin Nutr 2003, 77(4):943-951.
50. Schempp C.M., Windeck T., Hezel S., et al. Topical treatment of atopic dermatitis with St. John's wort cream-a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 2003, 10(Suppl 4):31-37.
51. Kotani M., Matsumoto M., Fujita A., et al. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol 2000, 106(1 Pt 1):159-166.
52. Matsumoto M., Kotani M., Fujita A., et al. Oral administration of persimmon leaf extract ameliorates skin symptoms and transepidermal water loss in atopic dermatitis model mice, NC/Nga. Br J Dermatol 2002, 146(2):221-227.
53. Qi X.F., Kim D.H., Yoon Y.S., et al. Effects of Bambusae caulis in Liquamen on the development of atopic dermatitis-like skin lesions in hairless mice. J Ethnopharmacol 2009, 123(2):195-200.
54. Joo S.S., Won T.J., Nam S.Y., et al. Therapeutic advantages of medicinal herbs fermented with Lactobacillus plantarum, in topical application and its activities on atopic dermatitis. Phytother Res 2009, 23(7):913-919.
55. Fung A.Y., Look P.C., Chong L.Y., et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999, 38(5):387-392.
56. Zhang W., Leonard T., Bath-Hextall F., et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 2005, (2). CD002291.
57. Hon K.L., Leung T.F., Wong Y., et al. A pentaherbs capsule as a treatment option for atopic dermatitis in children: an open-labeled case series. Am J Chin Med 2004, 32(6):941-950.
58. Hon K.L., Lee V.W., Leung T.F., et al. Corticosteroids are not present in a traditional Chinese medicine formulation for atopic dermatitis in children. Ann Acad Med Singapore 2006, 35(11):759-763.
59. Hon K.L., Leung T.F., Ng P.C., et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007, 157(2):357-363.
60. Leung T.F., Wong K.Y., Wong C.K., et al. In vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis. Br J Dermatol 2008, 158(6):1216-1223.
61. Chan B.C., Hon K.L., Leung P.C., et al. Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. J Ethnopharmacol 2008, 120(1):85-91.
62. Salameh F., Perla D., Solomon M., et al. The effectiveness of combined Chinese herbal medicine and acupuncture in the treatment of atopic dermatitis. J Altern Complement Med 2008, 14(8):1043-1048.
63. Nakada T., Watanabe K., Matsumoto T., et al. Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen. Int Immunopharmacol 2002, 2(7):901-911.
64. Kobayashi H., Ishii M., Takeuchi S., et al. Efficacy and safety of a traditional herbal medicine, Hochu-ekki-to in the long-term management of Kikyo (delicate constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Alternat Med 2008, [Epub ahead of print].
65. Makino T., Hamanaka M., Yamashita H., et al. Effect of bakumijiogan, an herbal formula in traditional Chinese medicine, on atopic dermatitis-like skin lesions induced by mite antigen in NC/Jic mice. Biol Pharm Bull 2008, 31(11):2108-2113.
66. Choi J.J., Park B., Kim D.H., et al. Blockade of atopic dermatitis-like skin lesions by DA-9102, a natural medicine isolated from Actinidia arguta, in the Mg-deficiency induced dermatitis model of hairless rats. Exp Biol Med (Maywood) 2008, 233(8):1026-1034.
67. Linde K., Clausius N., Ramirez G., et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997, 350(9081):834-843.
68. Itamura R. Effect of homeopathic treatment of 60 Japanese patients with chronic skin disease. Complement Ther Med 2007, 15(2):115-120.
69. Murphy G.M., Smith S.E., Smith S.A., et al. Autonomic function in cholinergic urticaria and atopic eczema. Br J Dermatol 1984, 110(5):581-586.
70. Boettger M.K., Bar K.J., Dohrmann A., et al. Increased vagal modulation in atopic dermatitis. J Dermatol Sci 2009, 53(1):55-59.
71. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007, 117(2):289-296.
72. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421(6921):384-388.
73. Masini E., Fantozzi R., Conti A., et al. Immunological modulation of cholinergic histamine release in isolated rat mast cells. Agents Actions 1985, 16(3-4):152-154.
74. Haynes S.N., Wilson C.C., Jaffe P.G., et al. Biofeedback treatment of atopic dermatitis: controlled case studies of eight cases. Biofeedback Self Regul 1979, 4(3):195-209.